Effects of prehospital medications on mortality and length of stay in congestive heart failure

doi:10.1016/S0196-0644(05)82777-5

Annals of Emergency Medicine

Volume 21, Issue 6, June 1992, Pages 669-674

https://doi.org/10.1016/S0196-0644(05)82777-5 Get rights and content

Hypothesis:

Prehospital medications for congestive heart failure should affect hospital outcomes (survival and length of stay). Study design: In a retrospective case series, hospital outcomes were compared for patients treated with prehospital nitroglycerin, furosemide, and/or morphine (252) versus those given no medications (241).

Setting:

A rural/suburban emergency medical services system (population 140,000) served by three paramedic units.

Participants:

Four hundred ninety-three consecutive cases of congestive heart failure or pulmonary edema were identified by hospital discharge diagnosis from a data base of 8,315 paramedic transports with known outcome.

Interventions:

Oxygen was given by protocol to 489 patients. Other medications were given by order of on-line physician medical command.

Results:

Overall mortality was 10.9% (54 of 493). Treated and untreated patients were comparable in age, sex, cardiac rhythms, prior use of cardiac medications, and response and scene times; mortality was reduced in treated versus untreated patients (odds ratio for improved survival, 2.51; 95% confidence interval, 1.37 to 4.55; P < .01). Positive treatment effect was greatest for 58 nonhypotensive, critical patients (odds ratio for survival, 10.25; P < .01). No single drug combination was unique in terms of treatment benefit. Patients treated in the field received medications 36 minutes earlier than patients first treated in the emergency department. No survival benefit was evident for noncritical, nonhypotensive patients, and patients with final diagnoses of asthma, chronic obstructive pulmonary disease, pneumonia, or bronchitis had a higher than expected mortality if erroneously treated for congestive heart failure. Differences in hospital length of stay were not significant for any group.

Conclusion:

Prehospital medications improve survival in congestive heart failure, especially in critical patients. More than one combination of medications seems effective, and early treatment is associated with improved survival. However, these medications appear to increase mortality in patients misdiagnosed in the field. Factors used in paramedic and medical command assessments require further study.

References (16)

ShusterM et al.
Pharmacologic intervention in prehospital care: A critical appraisal
Ann Emerg Med
(1989)
TreschDD et al.
Out-of-hospital pulmonary edema. Diagnosis and treatment
Ann Emerg Med
(1983)
HoffmanJR et al.
Comparison of nitroglycerin, morphine and furosemide in treatment of presumed prehospital pulmonary edema
Chest
(1987)
McNamaraRM et al.
Utility of the peak expiratory flow rate in the differentiation of acute dyspnea — Cardiac vs pulmonary origin
Chest
(1992)
BussmannWD et al.
Effect of sublingual nitroglycerin in emergency treatment of severe pulmonary edema
Am J Cardiol
(1978)
NelsonGIC et al.
Haemodynamic advantages of isosorbide dinitrate over frusemide in acute heart-failure following myocardial infarction
Lancet
(1983)
KereiakesDJ et al.
Time delays in the diagnosis and treatment of acute myocardial infarction: A tale of eight cities
Am Heart J
(1990)
FraciosaJA et al.
Survial in men with severe chronic left ventricular failure due to either coronary heart disease or idiopathic dilated cardiomyopathy
Am J Cardiol
(1983)

There are more references available in the full text version of this article.

Cited by (205)

Early intravenous vasodilator therapy in acute decompensated heart failure: Is the time-to-treat concept still applicable in a pre-hospital setting?
2022, International Journal of Cardiology
Patient care pathways in acute heart failure and their impact on in-hospital mortality, a French national prospective survey
2020, IJC Heart and Vasculature
Our purpose was to describe the care pathway of patients hospitalized for acute heart failure (AHF) and investigate whether a management involving a cardiology department had an impact on in-hospital mortality.
Between June 2014 and October 2018, we included patients hospitalized for AHF in 24 French hospitals. Characteristics of the episode, patient’s care pathway and outcomes were recorded on a specific assessment tool. The primary outcome was the association between patient care pathway and in-hospital mortality. The independent association between admission to a cardiology ward and in-hospital mortality was assessed through a multivariate regression model and propensity score matching.
A total of 3677 patients, mean age of 78, were included. The in-hospital mortality rate was 8% (n = 287) and was associated on multivariate regression with advanced age, presence of sepsis, of cardiogenic shock, high New York Heart Association (NYHA) score and increased plasma creatinine level on admission. High blood pressure and admission to a cardiology department appeared as protective factors. After propensity score matching, hospitalization in a cardiology department remained a protective factor of in-hospital mortality (OR = 0.61 [0.44–0.84], p = 0.002).
A hospital course of care involving a cardiology department was associated with an increase in hospital survival in AHF patients. These finding may highlight the importance of collaboration between cardiologists and other in-hospitals specialties, such as emergency physicians, in order to find the best in-hospital pathway for patients with AHF.
Clinical Trial NCT03903198.
Impact of the time-to-treatment concept on the outcome of acute heart failure: A pilot study
2018, Archives of Cardiovascular Diseases
An optimal maximum time of 60 minutes has been recommended in recent guidelines for the first evaluation and treatment of patients with acute heart failure (AHF); however, this has not been tested prospectively.
To analyze the impact of a time-to-treatment (TTT) strategy of < 60 minutes on the in-hospital outcome of patients with AHF.
During a single 1-month period, we consecutively enrolled all patients hospitalized with AHF in a prospective cohort. In this pilot study, TTT was defined as the time between the first medical contact to the onset of the first medical intervention. The primary outcome was a composite including in-hospital death or worsening AHF.
Of the 74 patients included, 23 (31%) had a TTT of < 60 minutes. Although these patients were more likely to have a more severe episode of AHF, the primary outcome occurred only in patients with a TTT of ≥ 60 minutes. The primary outcome was significantly associated with a TTT of ≥ 60 minutes (P = 0.036), low systolic blood pressure (P < 0.01), rales more than halfway up the lung fields (P = 0.02), infectious precipitating factor (P = 0.04) and high serum concentrations of B-type natriuretic peptide (P < 0.01) and urea (P = 0.03). No significant differences were observed in the rate of treatment-induced acute renal insufficiency or in the long-term rates of death or rehospitalization for heart failure according to TTT.
This study suggests that the recently recommended TTT strategy of < 60 minutes in the setting of AHF might be associated with a better prognosis during hospitalization. Further large prospective works are needed to confirm these preliminary results, and to define more precisely which types of AHF could benefit from this strategy.
Les dernières guidelines recommandent un délai optimal maximal de 60 minutes pour la première évaluation et le traitement des patients souffrant d’insuffisance cardiaque aiguë (ICA). Cependant, cette stratégie n’a jamais été évaluée prospectivement.
Dans une étude pilote, nous avons analysé l’impact d’un délai de prise en charge, défini comme « time-to-therapy » (TTT) < 60 minutes, sur le devenir des patients atteints d’ICA pendant la période hospitalière.
Au cours d’une période d’un mois, nous avons inclus consécutivement tous les patients hospitalisés pour ICA dans une cohorte prospective. Dans cette étude pilote, TTT a été définie comme le temps entre le premier contact médical et le début de la première intervention médicale. Le critère de jugement principal était composite et comprenait le décès ou l’aggravation de l’ICA pendant la période hospitalière.
Sur les 74 patients inclus, 23 patients (31 %) ont reçu une stratégie TTT < 60 minutes. Bien que ces patients présentaient des épisodes d’ICA plus sévères, le critère de jugement principal n’a été observé que chez les patients ayant reçu une stratégie TTT ≥ 60 minutes. Ce critère était significativement associé à TTT < 60 minutes (p = 0,036), une pression artérielle systolique plus basse (p < 0,01), des râles crépitants dépassant la moitié des champs pulmonaires (p = 0,02), un facteur précipitant infectieux (p = 0,04), un taux de BNP plus élevé (p < 0,01) et une urémie plus élevée (p = 0,03). Aucune différence significative n’a été observée concernant la survenue d’insuffisance rénale aiguë pendant l’hospitalisation ainsi que le taux de décès et réhospitalisation pour insuffisance cardiaque à long terme.
Cette étude pilote suggère que la stratégie recommandée de prise en charge < 60 minutes dans le cadre de l’ICA pourrait être associée à un meilleur pronostic hospitalier. D’autres grands travaux prospectifs sont nécessaires pour confirmer ces résultats préliminaires et définir plus précisément quels types d’ICA pourraient bénéficier de cette stratégie.
Accuracy of Lung Ultrasound in Patients with Acute Dyspnea: The Influence of Age, Multimorbidity and Cognitive and Motor Impairment
2017, Ultrasound in Medicine and Biology
Discriminating between causes of dyspnea may be difficult, particularly in the elderly. The aim of this retrospective study of 83 inpatients with acute dyspnea was to assess the influence of age, multimorbidity and cognitive or motor impairment on the diagnostic accuracy of lung ultrasound (LUS) in discriminating acute heart failure (AHF) from noncardiogenic dyspnea (NCD). Univariate analysis indicates that LUS misdiagnosis was associated with the following parameters: history of stroke (p = 0.037), lower activity of daily living (p = 0.039), higher modified-Rankin scale (mRS) (p = 0.027) and need of two operators to complete LUS because of reduced patient compliance (p = 0.030). Regression analysis identified only history of stroke (p = 0.048) as an independent predictor of LUS misdiagnosis. This study supports LUS usefulness to differentiate AHF from NCD. Our data suggest that diagnostic accuracy of LUS is affected by history of stroke as a proxy for severe motor impairment but not by age, cognitive impairment and multimorbidity.
Biosensors for the Rapid Detection of Cardiovascular Biomarkers of Vital Interest: Needs, Analysis and Perspectives
2022, Journal of Personalized Medicine
Head-to-head comparison of diagnostic scores for acute heart failure in the emergency department: results from the PARADISE cohort
2022, Internal and Emergency Medicine

View all citing articles on Scopus

: Presented at the 18th Annual Scientific Assembly, Pennsylvania Chapter of the American College of Emergency Physicians in Pittsburgh, April 1991, and the Society for Academic Emergency Medicine Annual Meeting in Washington, DC, May 1991.

View full text

Original contributionEffects of prehospital medications on mortality and length of stay in congestive heart failure

Hypothesis:

Setting:

Participants:

Interventions:

Results:

Conclusion:

Ann Emerg Med

Ann Emerg Med

Chest

Chest

Am J Cardiol

Lancet

Am Heart J

Survial in men with severe chronic left ventricular failure due to either coronary heart disease or idiopathic dilated cardiomyopathy

Am J Cardiol

Original contribution
Effects of prehospital medications on mortality and length of stay in congestive heart failure